Letter: are opioid prescriptions associated with hepatic encephalopathy in patients with compensated cirrhosis? Authors' reply.
Publication
, Journal Article
Moon, AM; Jiang, Y; Rogal, SS; Tapper, EB; Lieber, SR; Barritt, AS
Published in: Alimentary pharmacology & therapeutics
April 2020
Duke Scholars
Published In
Alimentary pharmacology & therapeutics
DOI
EISSN
1365-2036
ISSN
0269-2813
Publication Date
April 2020
Volume
51
Issue
7
Start / End Page
743 / 744
Related Subject Headings
- Prescriptions
- Liver Cirrhosis
- Humans
- Hepatic Encephalopathy
- Gastroenterology & Hepatology
- Cohort Studies
- Analgesics, Opioid
- 3214 Pharmacology and pharmaceutical sciences
- 3202 Clinical sciences
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Moon, A. M., Jiang, Y., Rogal, S. S., Tapper, E. B., Lieber, S. R., & Barritt, A. S. (2020). Letter: are opioid prescriptions associated with hepatic encephalopathy in patients with compensated cirrhosis? Authors' reply. Alimentary Pharmacology & Therapeutics, 51(7), 743–744. https://doi.org/10.1111/apt.15669
Moon, Andrew M., Yue Jiang, Shari S. Rogal, Elliot B. Tapper, Sarah R. Lieber, and A Sidney Barritt. “Letter: are opioid prescriptions associated with hepatic encephalopathy in patients with compensated cirrhosis? Authors' reply.” Alimentary Pharmacology & Therapeutics 51, no. 7 (April 2020): 743–44. https://doi.org/10.1111/apt.15669.
Moon AM, Jiang Y, Rogal SS, Tapper EB, Lieber SR, Barritt AS. Letter: are opioid prescriptions associated with hepatic encephalopathy in patients with compensated cirrhosis? Authors' reply. Alimentary pharmacology & therapeutics. 2020 Apr;51(7):743–4.
Moon, Andrew M., et al. “Letter: are opioid prescriptions associated with hepatic encephalopathy in patients with compensated cirrhosis? Authors' reply.” Alimentary Pharmacology & Therapeutics, vol. 51, no. 7, Apr. 2020, pp. 743–44. Epmc, doi:10.1111/apt.15669.
Moon AM, Jiang Y, Rogal SS, Tapper EB, Lieber SR, Barritt AS. Letter: are opioid prescriptions associated with hepatic encephalopathy in patients with compensated cirrhosis? Authors' reply. Alimentary pharmacology & therapeutics. 2020 Apr;51(7):743–744.
Published In
Alimentary pharmacology & therapeutics
DOI
EISSN
1365-2036
ISSN
0269-2813
Publication Date
April 2020
Volume
51
Issue
7
Start / End Page
743 / 744
Related Subject Headings
- Prescriptions
- Liver Cirrhosis
- Humans
- Hepatic Encephalopathy
- Gastroenterology & Hepatology
- Cohort Studies
- Analgesics, Opioid
- 3214 Pharmacology and pharmaceutical sciences
- 3202 Clinical sciences
- 1115 Pharmacology and Pharmaceutical Sciences